Avalon Investment & Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-24,918
| Closed | -$2.84M | – | 353 |
|
|
2018
Q4 | $2.84M | Buy |
24,918
+1,118
| +5% | +$127K | 0.07% | 182 |
|
|
2018
Q3 | $2.75M | Buy |
23,800
+1,663
| +8% | +$192K | 0.08% | 212 |
|
|
2018
Q2 | $2.29M | Buy |
22,137
+1,963
| +10% | +$203K | 0.07% | 210 |
|
|
2018
Q1 | $1.99M | Buy |
20,174
+1,939
| +11% | +$191K | 0.06% | 216 |
|
|
2017
Q4 | $1.55M | Sell |
18,235
-14,247
| -44% | -$1.21M | 0.05% | 221 |
|
|
2017
Q3 | $2.5M | Sell |
32,482
-243
| -0.7% | -$18.7K | 0.08% | 168 |
|
|
2017
Q2 | $2.55M | Buy |
32,725
+418
| +1% | +$32.5K | 0.08% | 166 |
|
|
2017
Q1 | $2.33M | Buy |
32,307
+3,143
| +11% | +$226K | 0.08% | 168 |
|
|
2016
Q4 | $1.81M | Buy |
29,164
+109
| +0.4% | +$6.77K | 0.07% | 172 |
|
|
2016
Q3 | $1.88M | Buy |
29,055
+197
| +0.7% | +$12.8K | 0.07% | 152 |
|
|
2016
Q2 | $1.83M | Buy |
28,858
+7,065
| +32% | +$447K | 0.07% | 134 |
|
|
2016
Q1 | $1.26M | Buy |
+21,793
| New | +$1.26M | 0.05% | 131 |
|